A review of biomedical applications of low-frequency magnetic fields and nanoparticles (LFMFs/NPs)
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (98)
Show source-provided references
1. Robert KA (2000) Static and low-frequency magnetic field effects: health risks and therapies. Rep Prog Phys 63:415. https://doi.org/10.1088/0034-4885/63/3/20410.1088/0034-4885/63/3/204 ↗
2. Prato FS (2015) Non-thermal extremely low frequency magnetic field effects on opioid related behaviors: snails to humans, mechanisms to therapy. Bioelectromagnetics 36:333–348. https://doi.org/10.1002/bem.2191810.1002/bem.21918 ↗
3. Thomas AW, Graham K, Prato FS, McKay J, Forster PM, Moulin DE, Chari S (2007) A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain. Pain Res Manage 12:626072. https://doi.org/10.1155/2007/62607210.1155/2007/626072 ↗
4. Nappini S, Bonini M, Bombelli FB, Pineider F, Sangregorio C, Baglioni P, Nordèn B (2011) Controlled drug release under a low frequency magnetic field: Effect of the citrate coating on magnetoliposomes stability. Soft Matter 7:1025–1037. https://doi.org/10.1039/C0SM00789G10.1039/C0SM00789G ↗
5. Tomitaka A, Takemura Y, Huang Z, Roy U, Nair M (2019) Magnetoliposomes in controlled-release drug delivery systems. Crit Rev Biomed Eng 47:495–505. https://doi.org/10.1615/CritRevBiomedEng.202003300210.1615/CritRevBiomedEng.2020033002 ↗
6. Repacholi MH, Greenebaum B (1999) Interaction of static and extremely low frequency electric and magnetic fields with living systems: health effects and research needs. Bioelectromagnetics 20:133–160. https://doi.org/10.1002/(SICI)1521-186X(1999)20:3%3c133::AID-BEM1%3e3.0.CO;2-O10.1002/(SICI)1521-186X(1999)20:3<133::AID-BEM1>3.0.CO;2-O ↗
7. Balcavage WX, Alvager T, Swez J, Goff CW, Fox MT, Abdullyava S, King MW (1996) A mechanism for action of extremely low frequency electromagnetic fields on biological systems. Biochem Biophys Res Commun 222:374–378. https://doi.org/10.1006/bbrc.1996.075110.1006/bbrc.1996.0751 ↗
8. Bauréus Koch CLM, Sommarin M, Persson BRR, Salford LG, Eberhardt JL (2003) Interaction between weak low frequency magnetic fields and cell membranes. Bioelectromagnetics 24:395–402. https://doi.org/10.1002/bem.1013610.1002/bem.10136 ↗
9. Rahbek UL, Tritsaris K, Dissing S (2005) Interactions of low frequency, pulsed electromagnetic fields with living tissue: biochemical responses and clinical results. Oral Biosci Med 2:29–40
10. Nittby H, Grafström G, Eberhardt JL, Malmgren L, Brun A, Persson BRR, Salford LG (2008) Radiofrequency and extremely low-frequency electromagnetic field effects on the blood-brain barrier. Electromagn Biol Med 27:103–126. https://doi.org/10.1080/1536837080206199510.1080/15368370802061995 ↗
11. Rivera-Gil P, Jimenez De Aberasturi D, Wulf V, Pelaz B, Del Pino P, Zhao Y, De La Fuente JM, Ruiz De Larramendi I, Rojo T, Liang X-J, Parak WJ (2013) The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. Acc Chem Res 46:743–749. https://doi.org/10.1021/ar300039j10.1021/ar300039j ↗
12. Luyts K, Napierska D, Nemery B, Hoet PHM (2013) How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations. Environ Sci Process Impacts 15:23–38. https://doi.org/10.1039/C2EM30237C10.1039/C2EM30237C ↗
13. Joudeh N, Linke D (2022) Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol 20:262. https://doi.org/10.1186/s12951-022-01477-810.1186/s12951-022-01477-8 ↗
14. Wang AZ, Gu F, Zhang L, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC (2008) Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther 8:1063–1070. https://doi.org/10.1517/14712598.8.8.106310.1517/14712598.8.8.1063 ↗
15. Arosio D, Casagrande C, Manzoni L (2012) Integrin-mediated drug delivery in cancer and cardiovascular diseases with peptide-functionalized nanoparticles. Current Med Chem 19:3128–51. https://doi.org/10.2174/09298671280078474810.2174/092986712800784748 ↗
16. Subbiah R, Veerapandian MS, Yun K (2010) Nanoparticles: functionalization and multifunctional applications in biomedical sciences. Curr Med Chem 17:4559–77. https://doi.org/10.2174/09298671079418302410.2174/092986710794183024 ↗
17. Lopez S, Hallali N, Lalatonne Y, Hillion A, Antunes JC, Serhan N, Clerc P, Fourmy D, Motte L, Carrey J (2022) Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields. Nanoscale Adv 4:421–436. https://doi.org/10.1039/d1na00474c10.1039/d1na00474c ↗
18. Silva AKA, Espinosa A, Kolosnjaj-Tabi J, Wilhelm C, Gazeau F (2016) Medical applications of iron oxide nanoparticles. Iron Oxides: From Nat Appl 425–72. https://doi.org/10.1002/9783527691395.ch1810.1002/9783527691395.ch18 ↗
19. Dulińska-Litewka J, Łazarczyk A, Hałubiec P, Szafrański O, Karnas K, Karewicz A (2019) Superparamagnetic iron oxide nanoparticles—current and prospective medical applications. Materials 12:617. https://doi.org/10.3390/ma1204061710.3390/ma12040617 ↗
20. Lin MM, Kim DK, El Haj AJ, Dobson J (2008) Development of superparamagnetic iron oxide nanoparticles (spions) for translation to clinical applications. IEEE Trans Nanobiosci 7:298–305. https://doi.org/10.1109/TNB.2008.201186410.1109/TNB.2008.2011864 ↗
21. Lamichhane N, Sharifabad ME, Hodgson B, Mercer T, Sen T (2022) Superparamagnetic iron oxide nanoparticles (spions) as therapeutic and diagnostic agents. Nanoparticle therapeutics, Elsevier, pp 455–97. https://doi.org/10.1016/B978-0-12-820757-4.00003-X10.1016/B978-0-12-820757-4.00003-X ↗
22. Amiri S, Shokrollahi H (2013) The role of cobalt ferrite magnetic nanoparticles in medical science. Mater Sci Eng, C 33:1–8. https://doi.org/10.1016/j.msec.2012.09.00310.1016/j.msec.2012.09.003 ↗
23. Kefeni KK, Msagati TA, Nkambule TT, Mamba BB (2020) Spinel ferrite nanoparticles and nanocomposites for biomedical applications and their toxicity. Mater Sci Eng, C 107:110314. https://doi.org/10.1016/j.msec.2019.11031410.1016/j.msec.2019.110314 ↗
24. Mukhtar A, Wu K, Cao X (2020) Magnetic nanowires in biomedical applications. Nanotechnology 31:433001. https://doi.org/10.1088/1361-6528/aba1ba10.1088/1361-6528/aba1ba ↗
25. Nana ABA, Marimuthu T, Kondiah PP, Choonara YE, Du Toit LC, Pillay V (2019) Multifunctional magnetic nanowires: design, fabrication, and future prospects as cancer therapeutics. Cancers 11:1956. https://doi.org/10.3390/cancers1112195610.3390/cancers11121956 ↗
26. Lee N, Hyeon T (2019) Magnetic nanoparticles for magnetic resonance imaging contrast agents. In: Darton NJ, Ionescu A, Llandro J (eds) Magnetic nanoparticles in biosensing and medicine. Cambridge, Cambridge University Press, pp 228–50. https://doi.org/10.1017/978113938122210.1017/9781139381222 ↗
27. Tripathy A, Nine MJ, Silva FS (2021) Biosensing platform on ferrite magnetic nanoparticles: synthesis, functionalization, mechanism and applications. Adv Coll Interface Sci 290:102380. https://doi.org/10.1016/j.cis.2021.10238010.1016/j.cis.2021.102380 ↗
28. Avasthi A, Caro C, Pozo‑Torres E, Leal MP, García-Martín ML (2020) Magnetic nanoparticles as MRI contrast agents. Surface-modified nanobiomaterials for electrochemical and biomedicine applications, pp 49–91. https://doi.org/10.1007/s41061-020-00302-w10.1007/s41061-020-00302-w ↗
29. Kafrouni L, Savadogo O (2016) Recent progress on magnetic nanoparticles for magnetic hyperthermia. Prog Biomater 5:147–160. https://doi.org/10.1007/s40204-016-0054-610.1007/s40204-016-0054-6 ↗
30. Koksharov YA (2009) Magnetism of nanoparticles: effects of size, shape, and interactions. In: Sergey PG (ed) Magnetic nanoparticles. Wiley, pp 197–254. https://doi.org/10.1002/9783527627561.ch610.1002/9783527627561.ch6 ↗
31. Malvandi A, Ganji D (2014) Magnetic field effect on nanoparticles migration and heat transfer of water/alumina nanofluid in a channel. J Magn Magn Mater 362:172–179. https://doi.org/10.1016/j.jmmm.2014.03.01410.1016/j.jmmm.2014.03.014 ↗
32. Bae J-E, Huh M-I, Ryu B-K, Do J-Y, Jin S-U, Moon M-J, Jung J-C, Chang Y, Kim E, Chi S-G (2011) The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 32:9401–9414. https://doi.org/10.1016/j.biomaterials.2011.08.07510.1016/j.biomaterials.2011.08.075 ↗
33. Shah RR, Davis TP, Glover AL, Nikles DE, Brazel CS (2015) Impact of magnetic field parameters and iron oxide nanoparticle properties on heat generation for use in magnetic hyperthermia. J Magn Magn Mater 387:96–106. https://doi.org/10.1016/j.jmmm.2015.03.08510.1016/j.jmmm.2015.03.085 ↗
34. Fatima H, Charinpanitkul T, Kim K-S (2021) Fundamentals to apply magnetic nanoparticles for hyperthermia therapy. Nanomaterials 11:1203. https://doi.org/10.3390/nano1105120310.3390/nano11051203 ↗
35. Hedayatnasab Z, Abnisa F, Daud WMAW (2017) Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application. Mater Des 123:174–196. https://doi.org/10.1016/j.matdes.2017.03.03610.1016/j.matdes.2017.03.036 ↗
36. Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G (2010) Recent advances in cancer therapy: an overview. Curr Pharm Des 16:3–10. https://doi.org/10.2174/13816121078994184710.2174/138161210789941847 ↗
37. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech 2:751–60. https://doi.org/10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
38. Khameneh AJ, Milani D, Babaei N, Hannani N, Heydarian A (2023) Effects of vitamins e and d on mechanical properties of breast cancerous cells. Curr Cancer Ther Rev 19:1–7. https://doi.org/10.2174/011573394726598223092915484310.2174/0115733947265982230929154843 ↗
39. Eskandari V, Sahbafar H, Zeinalizad L, Mahmoudi R, Karimpour F, Hadi A, Bardania H (2022) Coating of silver nanoparticles (AgNPs) on glass fibers by a chemical method as plasmonic surface-enhanced Raman spectroscopy (SERS) sensors to detect molecular vibrations of doxorubicin (dox) drug in blood plasma. Arab J Chem 15:104005. https://doi.org/10.1016/j.arabjc.2022.10400510.1016/j.arabjc.2022.104005 ↗
40. Eskandari V, Sahbafar H, Zeinalizad L, Hadi A (2022) A review of applications of surface-enhanced raman spectroscopy laser for detection of biomaterials and a quick glance into its advances for covid-19 investigations. ISSS J Micro Smart Syst 11:363–382. https://doi.org/10.1007/s41683-022-00103-x10.1007/s41683-022-00103-x ↗
41. Lee JH, Yeo Y (2015) Controlled drug release from pharmaceutical nanocarriers. Chem Eng Sci 125:75–84. https://doi.org/10.1016/j.ces.2014.08.04610.1016/j.ces.2014.08.046 ↗
42. Sethi M, Sukumar R, Karve S, Werner ME, Wang EC, Moore DT, Kowalczyk SR, Zhang L, Wang AZ (2014) Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity. Nanoscale 6:2321–2327. https://doi.org/10.1039/C3NR05961H10.1039/C3NR05961H ↗
43. Chien YW (1989) Rate-control drug delivery systems: Controlled release vs. Sustained release. Med Prog Technol 15:21–46
44. Senapati S, Mahanta AK, Kumar S, Maiti P (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 3:7. https://doi.org/10.1038/s41392-017-0004-310.1038/s41392-017-0004-3 ↗
45. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules 26:5905. https://doi.org/10.3390/molecules2619590510.3390/molecules26195905 ↗
46. Guimarães D, Cavaco-Paulo A, Nogueira E (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571. https://doi.org/10.1016/j.ijpharm.2021.12057110.1016/j.ijpharm.2021.120571 ↗
47. Kim J-S (2016) Liposomal drug delivery system. J Pharm Investig 46:387–392. https://doi.org/10.1007/s40005-016-0260-110.1007/s40005-016-0260-1 ↗
48. Lian T, Ho RJY (2001) Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667–680. https://doi.org/10.1002/jps.102310.1002/jps.1023 ↗
49. Zylberberg C, Matosevic S (2016) Pharmaceutical liposomal drug delivery: A review of new delivery systems and a look at the regulatory landscape. Drug Delivery 23:3319–3329. https://doi.org/10.1080/10717544.2016.117713610.1080/10717544.2016.1177136 ↗
50. Wilkinson HN, Hardman MJ (2020) Wound healing: cellular mechanisms and pathological outcomes. Open Biol 10:200223. https://doi.org/10.1098/rsob.20022310.1098/rsob.200223 ↗
51. Dong R, Guo B (2021) Smart wound dressings for wound healing. Nano Today 41:101290. https://doi.org/10.1016/j.nantod.2021.10129010.1016/j.nantod.2021.101290 ↗
52. Broughton G II, Janis JE, Attinger CE (2006) The basic science of wound healing. Plastic Reconstruct Surg 117. https://doi.org/10.1097/01.prs.0000225430.42531.c210.1097/01.prs.0000225430.42531.c2 ↗
53. Rodrigues M, Kosaric N, Bonham CA, Gurtner GC (2019) Wound healing: a cellular perspective. Physiol Rev 99:665–706. https://doi.org/10.1152/physrev.00067.201710.1152/physrev.00067.2017 ↗
54. Gonzalez ACdO, Costa TF, Andrade ZdA, Medrado ARAP (2016) Wound healing-a literature review. An Bras Dermatol 91:614–20. https://doi.org/10.1590/abd1806-4841.2016474110.1590/abd1806-4841.20164741 ↗
55. Sengupta S, Balla VK (2018) A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment. J Adv Res 14:97–111. https://doi.org/10.1016/j.jare.2018.06.00310.1016/j.jare.2018.06.003 ↗
56. Xu A, Wang Q, Lv X, Lin T (2021) Progressive study on the non-thermal effects of magnetic field therapy in oncology. Front Oncol 11. https://doi.org/10.3389/fonc.2021.63814610.3389/fonc.2021.638146 ↗
57. Liu JF, Jang B, Issadore D, Tsourkas A (2019) Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. WIREs Nanomed Nanobiotechnol 11:e1571. https://doi.org/10.1002/wnan.157110.1002/wnan.1571 ↗
58. Mertz D, Sandre O, Bégin-Colin S (2017) Drug releasing nanoplatforms activated by alternating magnetic fields. Biochimica et Biophysica Acta (BBA) - Gen Subj 1861:1617–41. https://doi.org/10.1016/j.bbagen.2017.02.02510.1016/j.bbagen.2017.02.025 ↗
59. Bi H, Chen Z, Qiu J, Chen Q (2021) Magnetic-field-triggered remote drug release and analysis of mechanism. Sens Mater 33. https://doi.org/10.18494/SAM.2021.346010.18494/SAM.2021.3460 ↗
60. Saliev T, Mustapova Z, Kulsharova G, Bulanin D, Mikhalovsky S (2014) Therapeutic potential of electromagnetic fields for tissue engineering and wound healing. Cell Prolif 47:485–493. https://doi.org/10.1111/cpr.1214210.1111/cpr.12142 ↗
61. Zhao J, Li Y-g, Deng K-q, Yun P, Gong T (2017) Therapeutic effects of static magnetic field on wound healing in diabetic rats. J Diabetes Res 2017:6305370. https://doi.org/10.1155/2017/630537010.1155/2017/6305370 ↗
62. Li W, Liu Y, Qian Z, Yang Y (2017) Evaluation of tumor treatment of magnetic nanoparticles driven by extremely low frequency magnetic field. Sci Rep 7:46287. https://doi.org/10.1038/srep4628710.1038/srep46287 ↗
63. Lazzarini R, Eléxpuru-Zabaleta M, Piva F, Giulietti M, Fulgenzi G, Tartaglione MF, Zingaretti L, Tagliabracci A, Valentino M, Santarelli L, Bracci M (2023) Effects of extremely low-frequency magnetic fields on human MDA-MB-231 breast cancer cells: proteomic characterization. Ecotoxicol Environ Saf 253:114650. https://doi.org/10.1016/j.ecoenv.2023.11465010.1016/j.ecoenv.2023.114650 ↗
64. Stratton D, Malibha-Pinchbeck M, Inal J (2022) Extremely low-frequency magnetic fields significantly enhance the cytotoxicity of methotrexate and can reduce migration of cancer cell lines via transiently induced plasma membrane damage. Biochem Biophys Res Commun 626:192–199. https://doi.org/10.1016/j.bbrc.2022.08.03510.1016/j.bbrc.2022.08.035 ↗
65. Guo Y, Yang W, Pu G, Zhu C, Zhu Y, Li J, Huang Y, Wang B, Chu M (2022) Low frequency vibrating magnetic field-triggered magnetic microspheres with a nanoflagellum-like surface for cancer therapy. J Nanobiotechnology 20:316. https://doi.org/10.1186/s12951-022-01521-710.1186/s12951-022-01521-7 ↗
66. Xu A, Wang Q, Lin T (2020) Low-frequency magnetic fields (LF-MFs) inhibit proliferation by triggering apoptosis and altering cell cycle distribution in breast cancer cells. Int J Mol Sci 21. https://doi.org/10.3390/ijms2108295210.3390/ijms21082952 ↗
67. Ashdown CP, Johns SC, Aminov E, Unanian M, Connacher W, Friend J, Fuster MM (2020) Pulsed low-frequency magnetic fields induce tumor membrane disruption and altered cell viability. Biophys J 118:1552–1563. https://doi.org/10.1016/j.bpj.2020.02.01310.1016/j.bpj.2020.02.013 ↗
68. Spyridopoulou K, Makridis A, Maniotis N, Karypidou N, Myrovali E, Samaras T, Angelakeris M, Chlichlia K, Kalogirou O (2018) Effect of low frequency magnetic fields on the growth of mnp-treated HT29 colon cancer cells. Nanotechnology 29:175101. https://doi.org/10.1088/1361-6528/aaaea910.1088/1361-6528/aaaea9 ↗
69. Huss A, Spoerri A, Egger M, Kromhout H, Vermeulen R (2018) Occupational extremely low frequency magnetic fields (ELF-MF) exposure and hematolymphopoietic cancers - swiss national cohort analysis and updated meta-analysis. Environ Res 164:467–474. https://doi.org/10.1016/j.envres.2018.03.02210.1016/j.envres.2018.03.022 ↗
70. Belyanina IV, Zamay TN, Zamay GS, Zamay SS, Kolovskaya OS, Ivanchenko TI, Denisenko VV, Kirichenko AK, Glazyrin YE, Garanzha IV, Grigorieva VV, Shabanov AV, Veprintsev DV, Sokolov AE, Sadovskii VM, Gargaun A, Berezovski MV, Kichkailo AS (2017) In vivo cancer cells elimination guided by aptamer-functionalized gold-coated magnetic nanoparticles and controlled with low frequency alternating magnetic field. Theranostics 7:3326–3337. https://doi.org/10.7150/thno.1708910.7150/thno.17089 ↗
71. Nie Y, Du L, Mou Y, Xu Z, Weng L, Du Y, Zhu Y, Hou Y, Wang T (2013) Effect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulation. BMC Cancer 13:582. https://doi.org/10.1186/1471-2407-13-58210.1186/1471-2407-13-582 ↗
72. Marrella A, Iafisco M, Adamiano A, Rossi S, Aiello M, Barandalla-Sobrados M, Carullo P, Miragoli M, Tampieri A, Scaglione S, Catalucci D (2018) A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: Potential application for cardiovascular diseases. J R Soc Interface 15. https://doi.org/10.1098/rsif.2018.023610.1098/rsif.2018.0236 ↗
73. Mahdikia H, Saadati F, Alizadeh AM, Khalighfard S, Bekeschus S, Shokri B (2023) Low-frequency magnetic fields potentiate plasma-modified magneto-electric nanoparticle drug loading for anticancer activity in vitro and in vivo. Sci Rep 13:17536. https://doi.org/10.1038/s41598-023-44683-610.1038/s41598-023-44683-6 ↗
74. Maron E, Krysinski P, Chudy M (2023) Controlled release of doxorubicin from magnetoliposomes assisted by low-frequency magnetic field. Chem Biodivers 20:e202201079. https://doi.org/10.1002/cbdv.20220107910.1002/cbdv.202201079 ↗
75. Burmistrov IA, Veselov MM, Mikheev AV, Borodina TN, Bukreeva TV, Chuev MA, Starchikov SS, Lyubutin IS, Artemov VV, Khmelenin DN, Klyachko NL, Trushina DB (2021) Permeability of the composite magnetic microcapsules triggered by a non-heating low-frequency magnetic field. Pharmaceutics 14. https://doi.org/10.3390/pharmaceutics1401006510.3390/pharmaceutics14010065 ↗
76. Golovin Y, Golovin D, Klyachko N, Majouga A, Kabanov A (2017) Modeling drug release from functionalized magnetic nanoparticles actuated by non-heating low frequency magnetic field. J Nanoparticle Res 19. https://doi.org/10.1007/s11051-017-3754-510.1007/s11051-017-3754-5 ↗
77. Fang J, Yang Y, Xiao W, Zheng B, Lv YB, Liu XL, Ding J (2016) Extremely low frequency alternating magnetic field-triggered and mri-traced drug delivery by optimized magnetic zeolitic imidazolate framework-90 nanoparticles. Nanoscale 8:3259–3263. https://doi.org/10.1039/c5nr08086j10.1039/c5nr08086j ↗
78. Guo H, Chen W, Sun X, Liu YN, Li J, Wang J (2015) Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydr Polym 118:209–217. https://doi.org/10.1016/j.carbpol.2014.10.07610.1016/j.carbpol.2014.10.076 ↗
79. Nappini S, Bonini M, Ridi F, Baglioni P (2011) Structure and permeability of magnetoliposomes loaded with hydrophobic magnetic nanoparticles in the presence of a low frequency magnetic field. Soft Matter 7:4801–4811. https://doi.org/10.1039/C0SM01264E10.1039/C0SM01264E ↗
80. Nappini S, Bombelli FB, Bonini M, Nordèn B, Baglioni P (2010) Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field. Soft Matter 6:154–162. https://doi.org/10.1039/B915651H10.1039/B915651H ↗
81. Vlasova KY, Piroyan A, Le-Deygen IM, Vishwasrao HM, Ramsey JD, Klyachko NL, Golovin YI, Rudakovskaya PG, Kireev II, Kabanov AV, Sokolsky-Papkov M (2019) Magnetic liposome design for drug release systems responsive to super-low frequency alternating current magnetic field (ac MF). J Colloid Interface Sci 552:689–700. https://doi.org/10.1016/j.jcis.2019.05.07110.1016/j.jcis.2019.05.071 ↗
82. Gualdi G, Costantini E, Reale M, Amerio P (2021) Wound repair and extremely low frequency-electromagnetic field: Insight from in vitro study and potential clinical application. Int J Mol Sci 22:5037. https://doi.org/10.3390/ijms2209503710.3390/ijms22095037 ↗
83. Cañedo-Dorantes L, Soenksen LR, García-Sánchez C, Trejo-Núñez D, Pérez-Chávez F, Guerrero A, Cardona-Vicario M, García-Lara C, Collí-Magaña D, Serrano-Luna G, Angeles Chimal JS, Cabrera G (2015) Efficacy and safety evaluation of systemic extremely low frequency magnetic fields used in the healing of diabetic foot ulcers–phase ii data. Arch Med Res 46:470–478. https://doi.org/10.1016/j.arcmed.2015.07.00210.1016/j.arcmed.2015.07.002 ↗
84. Glinka M, Sieroń A, Birkner E, Cieślar G (2013) Influence of extremely low-frequency magnetic field on the activity of antioxidant enzymes during skin wound healing in rats. Electromagn Biol Med 32:463–470. https://doi.org/10.3109/15368378.2012.74390610.3109/15368378.2012.743906 ↗
85. Pasi F, Sanna S, Paolini A, Alquati M, Lascialfari A, Corti ME, Liberto RD, Cialdai F, Monici M, Nano R (2016) Effects of extremely low-frequency magnetotherapy on proliferation of human dermal fibroblasts. Electromagn Biol Med 35:343–352. https://doi.org/10.3109/15368378.2016.113812310.3109/15368378.2016.1138123 ↗
86. Ahmed I, Vojisavljevic V, Pirogova E (2013) Design and development of an extremely low frequency (ELF) pulsed electromagnetic field (PEMF) system for wound healing promotion. In: Long M (ed) World congress on medical physics and biomedical engineering May 26-31, 2012, Beijing, China. IFMBE Proceedings, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29305-4_810.1007/978-3-642-29305-4_8 ↗
87. Zhang M, Li X, Bai L, Uchida K, Bai W, Wu B, Xu W, Zhu H, Huang H (2013) Effects of low frequency electromagnetic field on proliferation of human epidermal stem cells: an in vitro study. Bioelectromagnetics 34:74–80. https://doi.org/10.1002/bem.2174710.1002/bem.21747 ↗
88. Sunkari VG, Aranovitch B, Portwood N, Nikoshkov A (2011) Effects of a low-intensity electromagnetic field on fibroblast migration and proliferation. Electromagn Biol Med 30:80–85. https://doi.org/10.3109/15368378.2011.56677410.3109/15368378.2011.566774 ↗
89. Ibrahim I, Draeger T, Wittenberg T (2023) Identification of surgical instruments using a low frequency magnetic field. Curr Dir Biomed Eng 9(1):57–60. https://doi.org/10.1515/cdbme-2023-101510.1515/cdbme-2023-1015 ↗
90. Rydberg A, Guo Y, Velander J, Humblot P, Andersson G, Augustine Kachiramattom R, Mattsson M-O, Simko M (2018) Theranostic instrument based on the combination of low and high frequency EM-bio interaction for bone defects analysis and healing. In 2018 EMF-Med 1st world conference on biomedical applications of electromagnetic fields (EMF-Med) (pp. 1-2). IEEE, Split, Croatia, 10-13 September 2018. https://doi.org/10.23919/EMF-MED.2018.852604210.23919/EMF-MED.2018.8526042 ↗
91. Hallali N, Rocacher T, Crouzet C, Béard J, Douard T, Khalfaoui A, Dias Martin N, Chouzenoux F, Carrey J (2022) Low-frequency rotating and alternating magnetic field generators for biological applications: Design details of home-made setups. J Magn Magn Mater 564:170093. https://doi.org/10.1016/j.jmmm.2022.17009310.1016/j.jmmm.2022.170093 ↗
92. Lee S-K, Park S, Kim Y-W (2016) The effects of extremely low-frequency magnetic fields on reproductive function in rodents. Insights Animal Reprod. https://doi.org/10.5772/6242910.5772/62429 ↗
93. Stratton D, Lange S, Inal JM (2013) Pulsed extremely low-frequency magnetic fields stimulate microvesicle release from human monocytic leukaemia cells. Biochem Biophys Res Commun 430:470–475. https://doi.org/10.1016/j.bbrc.2012.12.01210.1016/j.bbrc.2012.12.012 ↗
94. Liu YX, Tai JL, Li GQ, Zhang ZW, Xue JH, Liu HS, Zhu H, Cheng JD, Liu YL, Li AM, Zhang Y (2012) Exposure to 1950-mhz td-scdma electromagnetic fields affects the apoptosis of astrocytes via caspase-3-dependent pathway. PLoS ONE 7:e42332. https://doi.org/10.1371/journal.pone.004233210.1371/journal.pone.0042332 ↗
95. Patruno A, Tabrez S, Amerio P, Pesce M, Vianale G, Franceschelli S, Grilli A, Kamal MA, Reale M (2011) Kinetic study on the effects of extremely low frequency electromagnetic field on catalase, cytochrome p450 and inducible nitric oxide synthase in human hacat and thp-1 cell lines. CNS Neurol Disord Drug Targets 10:936–944. https://doi.org/10.2174/18715271179921932510.2174/187152711799219325 ↗
96. Noroozi R, Arif ZU, Taghvaei H, Khalid MY, Sahbafar H, Hadi A, Sadeghianmaryan A, Chen X (2023) 3d and 4d bioprinting technologies: a game changer for the biomedical sector? Ann Biomed Eng 51:1683–1712. https://doi.org/10.1007/s10439-023-03243-910.1007/s10439-023-03243-9 ↗
97. Mohtadi Jafari A, Abdolali A (2018) Manipulation of the electromagnetic near-fields by 3d printed coils: from design to fabrication. IET Microwaves Antennas Propag 12:1461–1465. https://doi.org/10.1049/iet-map.2017.096110.1049/iet-map.2017.0961 ↗
98. Galarreta-Rodriguez I, Lopez-Ortega A, Garayo E, Beato-López JJ, La Roca P, Sanchez-Alarcos V, Recarte V, Gómez-Polo C, Pérez-Landazábal JI (2023) Magnetically activated 3d printable polylactic acid/polycaprolactone/magnetite composites for magnetic induction heating generation. Adv Composites Hybrid Mater 6:102. https://doi.org/10.1007/s42114-023-00687-410.1007/s42114-023-00687-4 ↗